![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
A Pinto, NG Abraham and KM Mullane
The authors have recently identified a cytochrome P-450-dependent monooxygenase in vascular tissue, localized primarily to the endothelium. As this enzyme system can metabolize arachidonic acid (AA) to novel products, some of which produce vasodilation, the pathways involved in the vascular actions of AA (10(-8) to 5 X 10(-6) M) were examined on rings of rabbit pulmonary artery. In pulmonary rings with a low basal tension (1.5 g), AA produces a weak contraction which is prevented by removal of the endothelium or the addition of indomethacin (10(-6) M) but not SKF 525A (10(-5) M), suggesting the formation of an endothelial-dependent vasoconstrictor cyclooxygenase product. In contrast, rings precontracted to 3.5 to 4 g tension with phenylephrine (7 X 10(-7) M) exhibit a dose-related relaxation to AA, which is significantly greater (P less than .001, n = 32) in preparations with an intact endothelium. The endothelium-independent relaxation is suppressed by indomethacin whereas indomethacin fails to attenuate the endothelium-dependent response. In contrast, SKF 525A, an inhibitor of cytochrome P-450-dependent monooxygenase, markedly inhibits (P less than .001) AA-induced relaxations in intact rings in a dose-dependent manner while not affecting the response in rings denuded of endothelium. Intact vessels treated with SKF 525A (10(-6) M) appear to show diversion of the AA to vasodilator cyclooxygenase products, since the subsequent addition of indomethacin produces a further reduction of the AA-induced relaxations, whereas by itself indomethacin has no effect.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  Q. Xie, Y. Zhang, C. Zhai, and J. A. Bonanno Calcium Influx Factor from Cytochrome P-450 Metabolism and Secretion-like Coupling Mechanisms for Capacitative Calcium Entry in Corneal Endothelial Cells J. Biol. Chem., May 3, 2002; 277(19): 16559 - 16566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Schlezinger and J. J. Stegeman Dose and Inducer-Dependent Induction of Cytochrome P450 1A in Endothelia of the Eel, including in the Swimbladder Rete Mirabile, a Model Microvascular Structure Drug Metab. Dispos., June 1, 2000; 28(6): 701 - 708. [Abstract] [Full Text]
|
|
|
|
|
|
S. L. Pfister, N. Spitzbarth, K. Nithipatikom, W. S. Edgemond, J. R. Falck, and W. B. Campbell Identification of the 11,14,15- and 11,12,15-Trihydroxyeicosatrienoic Acids as Endothelium-derived Relaxing Factors of Rabbit Aorta J. Biol. Chem., November 20, 1998; 273(47): 30879 - 30887. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Miura and D. D. Gutterman Human Coronary Arteriolar Dilation to Arachidonic Acid Depends on Cytochrome P-450 Monooxygenase and Ca2+-Activated K+ Channels Circ. Res., September 7, 1998; 83(5): 501 - 507. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Stephenson, R. S. Sprague, and A. J. Lonigro 5,6-Epoxyeicosatrienoic acid reduces increases in pulmonary vascular resistance in the dog Am J Physiol Heart Circ Physiol, July 1, 1998; 275(1): H100 - H109. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Chen and D. W. Cheung Modulation of Endothelium-Dependent Hyperpolarization and Relaxation to Acetylcholine in Rat Mesenteric Artery by Cytochrome P450 Enzyme Activity Circ. Res., October 1, 1996; 79(4): 827 - 833. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
